Radcliffe Capital Management’s Biote Corp. Warrant BTMDW Stock Holding History

Radcliffe Capital Management’s Portfolio BTMDW Stock Details BTMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-64,377	Closed	-$240K	–	759
2022 Q4	$240K	Sell	64,377 -59,223	-48%	-$16.1K	0.01%	823
2022 Q3	$529K	Hold	123,600	–	–	0.01%	1055
2022 Q2	$466K	Sell	123,600 -1,400	-1%	-$755	0.01%	1139
2022 Q1	$1.24M	Hold	125,000	–	–	0.03%	876
2021 Q4	$1.23M	Hold	125,000	–	–	0.03%	763
2021 Q3	$1.22M	Hold	125,000	–	–	0.04%	653
2021 Q2	$1.21M	Buy	+125,000	New	+$108K	0.04%	680

Other funds holding BTMDW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

SRF

Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Radcliffe Capital Management's BTMDW Position: Q1 2023 in Review

Radcliffe Capital Management sold out of Biote Corp. Warrant (BTMDW) in Q1 2023, closing a stake of 64,377 shares — an estimated $240K sold.

Radcliffe Capital Management first reported a position in BTMDW in Q2 2021 and held it in 7 quarters. The position peaked at $1.24M in Q1 2022. 34 funds tracked by Wall St. Rank hold BTMDW as of Q1 2023.

Radcliffe Capital Management reported no remaining Biote Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Radcliffe Capital Management sold 64,377 Biote Corp. Warrant shares in Q1 2023, an estimated $240K.
Radcliffe Capital Management first reported a position in Biote Corp. Warrant in Q2 2021 and held it in 7 quarters.
Radcliffe Capital Management's Biote Corp. Warrant position peaked at $1.24M in Q1 2022.
34 funds tracked by Wall St. Rank held Biote Corp. Warrant as of Q1 2023.

Based on Radcliffe Capital Management's 13F filing for Q1 2023, filed 15 May 2023.